2013
DOI: 10.1016/j.mrfmmm.2013.08.004
|View full text |Cite
|
Sign up to set email alerts
|

Chromosomal radiosensitivity in patients with multiple sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
4
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 25 publications
1
4
0
Order By: Relevance
“…Furthermore, evidences have suggested that impaired DNA repair might also play a fundamental role in the development of agerelated neurodegenerative diseases such as amyotrophic lateral sclerosis and Huntington's disease (Coppedè and Migliore 2010). Regarding the low genetic damage in lymphocytes, same result was found by Milenkova et al (Milenkova et al 2013) in patients with RRMS (treated with immunomodulators) and SPMS (not treated with immunomodulators).…”
Section: Discussionsupporting
confidence: 83%
“…Furthermore, evidences have suggested that impaired DNA repair might also play a fundamental role in the development of agerelated neurodegenerative diseases such as amyotrophic lateral sclerosis and Huntington's disease (Coppedè and Migliore 2010). Regarding the low genetic damage in lymphocytes, same result was found by Milenkova et al (Milenkova et al 2013) in patients with RRMS (treated with immunomodulators) and SPMS (not treated with immunomodulators).…”
Section: Discussionsupporting
confidence: 83%
“…Similarly, elevated MN frequency has been reported in patients with cancer [28], rheumatoid arthritis [29], autoimmune diseases [30], and premature aging syndrome [31]. The presence of MN in a cell is an indicator of DNA damage and genetic instability, and it could be associated with the collateral complications in these patients and with future risk of cancer development in humans.…”
Section: Periodontitis and Oxs: Nuclear And Oxidative Dna Damagementioning
confidence: 85%
“…Four types of MS have been characterized: relapsing-remitting (RRMS), secondary progressive (SPMS), primary progressive (PPMS), and progressive relapsing (PRMS). The RRMS form is present in 85% of patients at disease onset, but later during the course most of them will develop the SPMS form [ 24 ]. We found two studies about MN in MS patients; they were performed to evaluate the resistance to radiation of lymphocytes from MS patients; resistance to radiation is defined as the capacity of lymphocytes to prevent the formation of MN after radiation.…”
Section: Resultsmentioning
confidence: 99%
“…When patients and healthy subjects were analyzed before and after irradiation the induction of MN was evident, although frequencies tended to be higher in healthy subjects after radiation; this fact could be the consequence of a defective proliferation rate in patients with MS or can be the reflection of MS therapies that render CD4+ T cells resistant to MN formation after radiation when compared to cells derived from healthy subjects. Lately in 2013, Milenkova et al [ 24 ] reported that immunomodulatory therapy with IFN- β or glatiramer acetate in RRMS patients reduces the number of MN in binucleated cells induced by in vitro γ -irradiation. This data suggests that the resistance to radiation by T lymphocytes in MS patients is mainly due to treatment with immunomodulatory agents.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation